From: The accuracy of whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the detection of ovarian cancer relapse in patients with rising cancer antigen 125 (CA-125) levels
Histopathological diagnosis
Count
%
Serous cystadenocarcinoma
22
44
Mucinous cystadenocarcinoma
19
38
Endometrioid carcinoma
4
8
Clear cell carcinoma
2
Mixed cystadenocarcinoma
Dysgerminoma
1